--- title: TRC Healthcare | Insights Newsletter April 2026 description: Get the top Letter articles for April, don't miss our upcoming live CE webinars, explore popular clinical resources, and more! --- [![TRC Healthcare](https://info.trchealthcare.com/hubfs/_TRC%20Logos%202022/TRC%20Healthcare/TRC%20Logo%20-%20LP.svg) ](https://trchealthcare.com/category/resources/) [![Insights: Emerging Trends for Clinical Leadership](https://info.trchealthcare.com/hs-fs/hubfs/trc_Insights_1300x300_text.png?width=1300&height=300&name=trc_Insights_1300x300_text.png) ](https://trchealthcare.com/insights-newsletter-april-2026-emerging-trends-for-clinical-leadership/) **April 2026** ### Updates You Don't Want Your Team to Miss Anticipate Earlier CGM Use for Diabetes ** ** American Diabetes Association guidelines now recommend CGM at diagnosis or anytime after for patients on insulin or other meds that can cause hypoglycemia. Our articles discuss differences between the Rx CGM devices, point out important considerations with these devices, and give advice about patient counseling. We also give guidance about OTC options and their pros and cons. Readers can dig into our [*Continuous Glucose Monitoring*](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Continuous-Glucose-Monitoring-11921) chart for FAQs, product comparisons, troubleshooting tips, and advice on interpreting results.   **Read More**: - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Articles/PLH/2026/Apr/Prevent-Problems-When-CGM-Devices-Are-Used-In-House) - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Articles/PTLH/2026/Apr/Prevent-Problems-When-CGM-Devices-Are-Used-In-House) - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Articles/PL/2026/Apr/Anticipate-Earlier-CGM-Use-for-Diabetes) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Articles/PTL/2026/Apr/Expect-Patients-to-Use-CGM-Devices-Earlier-in-Diabetes) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Articles/PRL/2026/Apr/Consider-Offering-CGM-Earlier-for-Diabetes) Community Pharmacies: Separate Fact from Fiction About Antimicrobial Stewardships  ** ** Antimicrobial resistance continues to be a public health threat. Our articles dive into common rumors related to antibiotics and antimicrobial stewardship including how long common infections really need to be treated, if patients always need to continue their full antibiotic course, and whether certain types of antibiotics are truly more effective. Readers can get more guidance in our [Antimicrobial Stewardship](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2015/Sep/Antimicrobial-Stewardship-8866) toolbox.   **Read More**: - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Articles/PL/2026/Apr/Antimicrobial-Stewardship-Separate-Facts-From-Fiction) - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Articles/PLC/2026/Apr/Antimicrobial-Stewardship-Separate-Fact-From-Fiction) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Articles/PTL/2026/Apr/Sort-Out-Fact-From-Fiction-Around-Antimicrobial-Stewardship) - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Articles/PTLC/2026/Apr/Sort-Out-Fact-From-Fiction-Around-Antimicrobial-Stewardship) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Articles/PRL/2026/Apr/Antimicrobial-Stewardship-Separate-Facts-From-Fiction) Hospitals: Clarify Evolving Data Around Antibiotics for Variceal Bleeds ** ** There’s growing debate about whether to use prophylactic antibiotics after variceal hemorrhages in patients with cirrhosis. Our articles review why patients with cirrhosis and variceal bleeding have traditionally received prophylactic antibiotics, and summarizes emerging data questioning how much these regimens still improve outcomes. We also outline what to recommend now (ceftriaxone 1 g IV every 24 hours), when shorter courses (2–3 days) may be reasonable in select stable patients, and practical tips such as using clear stop times and considering alternatives when ceftriaxone can’t be used. Readers can review indications and choices for long-term prophylaxis in our chart, [*Decompensated Chronic Liver Failure*](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Aug/Decompensated-Chronic-Liver-Failure-12592). **Read More**: - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Articles/PLH/2026/Apr/Clarify-Evolving-Data-Around-Antibiotics-for-Variceal-Bleeds) - [Hospital Pharmacy Technician's Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Articles/PTLH/2026/Apr/Help-Coordinate-Antibiotics-for-GI-Bleeds-With-Cirrhosis) ### Natural Medicines [![Migraine X-1](https://info.trchealthcare.com/hs-fs/hubfs/Migraine%20X-1.png?width=1600&height=900&name=Migraine%20X-1.png) ](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/April2026/Managing-Migraines) ### Managing Migraines   Migraines affect about 10% of the population, and managing symptoms is an ongoing challenge. Many patients seek natural options for both prevention and treatment. Our [NatMed article](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/April2026/Managing-Migraines) covers key options for migraine prevention and treatment. A specific butterbur extract reduces migraine frequency by about 48%. Coenzyme Q10 is considered possibly effective by the American Academy of Neurology – though it can take up to 3 months to see results. And caffeine combined with acetaminophen, aspirin, or sumatriptan is effective for treating acute migraine. [![Migraine X-1](https://info.trchealthcare.com/hs-fs/hubfs/Migraine%20X-1.png?width=1600&height=900&name=Migraine%20X-1.png) ](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/April2026/Managing-Migraines) ### Managing Migraines   Migraines affect about 10% of the population, and managing symptoms is an ongoing challenge. Many patients seek natural options for both prevention and treatment. Our [NatMed article](https://naturalmedicines.therapeuticresearch.com/Content/nm/Newsletters/April2026/Managing-Migraines) covers key options for migraine prevention and treatment. A specific butterbur extract reduces migraine frequency by about 48%. Coenzyme Q10 is considered possibly effective by the American Academy of Neurology – though it can take up to 3 months to see results. And caffeine combined with acetaminophen, aspirin, or sumatriptan is effective for treating acute migraine. ### New Podcast! Natural Medicines: Evidence in Practice Our new podcast, Natural Medicines: Evidence in Practice, is now streaming! In our latest episode, *[Aging Skin: Choosing Treatments in a Hype‑Heavy Space](https://trchealthcare.com/natural-medicines-evidence-in-pratice-aging-skin-choosing-treatments-in-a-hype-heavy-space/)*, our editors break down the evidence behind common aging‑skin ingredients and discuss how pharmacists can help patients set realistic expectations while navigating a hype‑heavy space at the point of care. [![Podcast Episodes](https://no-cache.hubspot.com/cta/default/229441/d3049453-1bc9-4d89-b9fe-b0b6444a6713.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/d3049453-1bc9-4d89-b9fe-b0b6444a6713) ### Pharmacy and Prescriber Podcasts #### Medication Talk Listen to this month’s podcast episode, *[GLP-1 Agonists: Clinical Conundrums](https://learning.therapeuticresearch.com/mod/url/view.php?id=29115&opt_id=undefined)*, as our expert panel tackles real-world questions about **GLP-1 agonists**, from starting them and setting expectations with patients to strategies for switching agents. You’ll also hear them review key considerations to limit muscle loss with GLP-1 agonist use and discuss why some patients hit a plateau or don’t respond to GLP-1 agonists.  All Medication Talk episodes offer CE credit to Pharmacist’s Letter and Prescriber Insights subscribers for 2 years after the episode release date. Go to the [CE/CME & Training Organizer](https://learning.therapeuticresearch.com/local/trc_courselist/library.php?opt_id=oeu1740668995814r0.009425414181391867) and search “podcast” to find available courses.   ![medication talk on phone with headphones ](https://info.trchealthcare.com/hs-fs/hubfs/medication%20talk%20on%20phone%20with%20headphones%20.png?width=1081&height=712&name=medication%20talk%20on%20phone%20with%20headphones%20.png) #### Rumor vs Truth Listen to the latest episode, *[Artificial Intelligence](https://learning.therapeuticresearch.com/mod/url/view.php?id=29012&opt_id=undefined)*, as our editors explore dive into current claims around artificial intelligence in pharmacy practice to sort out which ones are medical truths versus risky rumors.  All Rumor vs Truth podcast episodes offer CE credit to subscribers for 2 years after their release date. Go to the [CE/CME & Training Organizer](https://learning.therapeuticresearch.com/local/trc_courselist/library.php?opt_id=oeu1740668995814r0.009425414181391867) and search “podcast” to find available courses.   #### **Clinical Capsules** Listen to our latest episode, *[Managing Opioid Overdose: Signs, Symptoms, and Reversal Agents](https://learning.therapeuticresearch.com/mod/url/view.php?id=29227&opt_id=undefined)*, as Associate Editor and Clinical Pharmacist Don Weinberger discusses how to recognize opioid overdose, compares naloxone and nalmefene options including the new nalmefene auto-injector, and shares tips for patients and caregivers on using opioid reversal agents effectively. All Clinical Capsules podcast episodes offer CE credit to subscribers for 2 years after their release date. Go to the [CE/CME & Training Organizer](https://learning.therapeuticresearch.com/local/trc_courselist/library.php?opt_id=oeu1740668995814r0.009425414181391867) and search “podcast” to find available courses. ### Upcoming Live CE Webinars for Your Clinicians **Pharmacotherapy of Urinary Tract Infections: From Asymptomatic Bacteriuria to Complicated Infections** **Dates: April 14 and 16  ** In this month’s live webinar, [*Pharmacotherapy of Urinary Tract Infections: From Asymptomatic Bacteriuria to Complicated Infections*](https://learning.therapeuticresearch.com/course/view.php?id=7225), you’ll hear our panelists discuss the latest approaches for addressing hot flashes, vaginal dryness, and other common symptoms of menopause (poor sleep, irritability, etc.). And you’ll listen as our panelists review hormonal and nonhormonal treatment options for patients experiencing menopausal symptoms. Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME:  - ACCME: 1.00 hour  - ACPE: 1.00 hour – pharmacists and technicians  - ANCC: 1.00 hour  [![Register Now](https://no-cache.hubspot.com/cta/default/229441/4ef419c9-69ea-45a6-8aa2-59d12ee87f2d.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/4ef419c9-69ea-45a6-8aa2-59d12ee87f2d) #### Pharmacy Essential Updates  **Upcoming 2026 Live Webinars **Check out our upcoming [Pharmacy Essential live CE webinars](https://learning.therapeuticresearch.com/local/webinar/reports/upcoming_webinars.php).  Topics for April include: - Continuous Glucose Monitoring Updates - Managing Metabolic Dysfunction-Associated Steatohepatitis (MASH) - New guidelines for managing gastroparesis *Pharmacists and pharmacy technicians can earn 1 Hour of CE for each attended webinar.  [![View Live CE Webinars](https://no-cache.hubspot.com/cta/default/229441/5f6625a8-59d0-4996-9efb-3f9d9a903e79.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/5f6625a8-59d0-4996-9efb-3f9d9a903e79) ### Popular Clinical Resources Continuous Glucose Monitoring ** **  Post our resource to help patients compare available options and answer FAQs.  - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Continuous-Glucose-Monitoring-11921) - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Continuous-Glucose-Monitoring-11921) - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Continuous-Glucose-Monitoring-11921) - [Pharmacist's Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Continuous-Glucose-Monitoring-11921) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Continuous-Glucose-Monitoring-11921) - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Continuous-Glucose-Monitoring-11921) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2018/Feb/Continuous-Glucose-Monitoring-11921) Nasal Sprays for Allergic Rhinitis ** ** Keep our chart on hand to compare available nasal spray options as we enter allergy season. - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2016/Apr/Nasal-Sprays-for-Allergic-Rhinitis-9572) - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2016/Apr/Nasal-Sprays-for-Allergic-Rhinitis-9572) - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2016/Apr/Nasal-Sprays-for-Allergic-Rhinitis-9572) - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2016/Apr/Nasal-Sprays-for-Allergic-Rhinitis-9572) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2016/Apr/Nasal-Sprays-for-Allergic-Rhinitis-9572) - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2016/Apr/Nasal-Sprays-for-Allergic-Rhinitis-9572) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2016/Apr/Nasal-Sprays-for-Allergic-Rhinitis-9572) Artificial Intelligence in Pharmacy Practice ** ** Review our resource for general AI concepts and guidance about potential uses in pharmacy practice.  - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2025/Oct/Artificial-Intelligence-in-Pharmacy-Practice-S2510010) Comparison of Treatments for Eczema (Atopic Dermatitis) ** ** Refer to our resource for quick answers about available options by age, dosing, cost, and other considerations. - [Hospital Pharmacist’s Letter](https://hospital-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2017/Feb/Comparison-of-Treatments-for-Eczema-Atopic-Dermatitis-10711) - [Hospital Pharmacy Technician’s Letter](https://hospital-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2017/Feb/Comparison-of-Treatments-for-Eczema-Atopic-Dermatitis-10711) - [Pharmacist’s Letter](https://pharmacist.therapeuticresearch.com/Content/Segments/PRL/2017/Feb/Comparison-of-Treatments-for-Eczema-Atopic-Dermatitis-10711) - [Pharmacist’s Letter Canada](https://ca-pharmacist.therapeuticresearch.com/Content/Segments/PRL/2017/Feb/Comparison-of-Treatments-for-Eczema-Atopic-Dermatitis-10711) - [Pharmacy Technician’s Letter](https://pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2017/Feb/Comparison-of-Treatments-for-Eczema-Atopic-Dermatitis-10711) - [Pharmacy Technician’s Letter Canada](https://ca-pharmacytech.therapeuticresearch.com/Content/Segments/PRL/2017/Feb/Comparison-of-Treatments-for-Eczema-Atopic-Dermatitis-10711) - [Prescriber Insights](https://prescriber.therapeuticresearch.com/Content/Segments/PRL/2017/Feb/Comparison-of-Treatments-for-Eczema-Atopic-Dermatitis-10711) #### Product Spotlight **New! Specialty Pharmacy Training Library** Specialty pharmacy is becoming more complex and harder to standardize across teams and sites. Many organizations are finding that clinical education alone isn’t enough to ensure consistent execution. That’s why we’ve built the [Specialty Pharmacy Training Library](https://info.trchealthcare.com/trc-healthcare-specialty-pharmacy-solutions), a new offering included within our Pharmacy Workforce Solutions. This library is just one way you can help your teams move beyond fragmented training and deliver consistent, high-quality specialty care.  **It combines:** - Accredited specialty education across key disease states - Clinical guidance resources, tools, and job aids for real-time decision-making - Workflow-based training across access, dispensing, monitoring, and adherence - Integrated assignment, tracking, and reporting tools for workforce visibility **The Specialty Pharmacy Training Library is included within:**  - [Pharmacist Learning & Practice Suite](https://trchealthcare.com/group-purchases/pharmacist-suite/) - [Pharmacy Technician Learning & Practice Suite ](https://trchealthcare.com/group-purchases/pharmacy-technician-suite/) We'd love to walk you through the new library as a resource to support your specialty pharmacy team.  [![Request Information](https://no-cache.hubspot.com/cta/default/229441/9d6edacf-1d3c-4118-9847-3d27a0aba136.png)](https://cta-redirect.hubspot.com/cta/redirect/229441/9d6edacf-1d3c-4118-9847-3d27a0aba136) ![TRC Healthcare](https://info.trchealthcare.com/hs-fs/hubfs/_TRC%20Logos/TRC%20Healthcare/TRC%20Logo%20-%20EM.png?width=400&height=121&name=TRC%20Logo%20-%20EM.png) ##### Compliance Gaps Create Financial Risk Gaps in pharmacy compliance don’t just create risk; they create real financial exposure, from audit findings to reimbursement impact.  The Pharmacy Compliance Suite powered by Bula, connects trusted regulatory insight to day-to-day operations, so you can keep compliance on track and avoid gaps that lead to risk. - Stay aligned with regulatory changes without manual tracking.  - Be prepared for audits with documentation already in place.  - Reduce risk across teams and locations.   - Keep compliance consistent across sites. [ Request a Demo ](https://info.trchealthcare.com/pharmacy-compliance-suite-ppc) ### About TRC Healthcare ###### TRC Healthcare provides unbiased education, training, and support to every healthcare professional to reduce knowledge gaps, encourage evidence-based practice, lower costs, and deliver better patient outcomes. ![](https://info.trchealthcare.com/hubfs/raw_assets/public/TRC/Images/logoIcon.svg) - [ Contact Us ](https://trchealthcare.com/contact-us/) - [ Privacy Policy ](https://info.trchealthcare.com/data-usage-policy) [![TRC Healthcare](https://info.trchealthcare.com/hubfs/_TRC%20Logos/TRC%20Healthcare/TRC%20Logo%20-%20LP.svg) ](https://www.trchealthcare.com) © 2026 TRC Healthcare. All Rights Reserved.